Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
Arch. latinoam. nutr ; 71(1): 54-60, mar. 2021. tab
Article in Spanish | LILACS, LIVECS | ID: biblio-1283254

ABSTRACT

La enfermedad por coronavirus (COVID-19) es altamente contagiosa y las medidas de confinamiento dinámico han demostrado que reducen significativamente el número de contagios, sin embargo, pueden alterar la disponibilidad de alimentos afectando la adherencia a la dieta libre de gluten (DLG) y la calidad de vida (CV) en la enfermedad celiaca (EC). El objetivo de este estudio fue evaluar los factores que limitan, la adherencia a la dieta libre de gluten y la calidad de vida en personas con enfermedad celiaca en periodo de pandemia por COVID-19. Métodos Se aplicaron encuestas on-line respecto a adherencia a la DLG, CV y acerca de los factores que han generado dificultad para llevar una DLG en este escenario. Resultados Se analizaron 216 encuestas de enfermos celiacos, mayores de 15 años, de los cuales un 91% eran mujeres con un promedio de edad de 36 + 10,7 años y con 5,8 + 6,0 años de enfermedad. El 56,48% tenía una excelente adherencia a la DLG y un 43,52% una buena CV. El costo elevado de los alimentos sin gluten fue la pregunta con mayor porcentaje de respuesta, asociándose con regular y mala adherencia a la DLG (valor p=0,001) y con pobre CV (valor p=0,023). Conclusión En periodo de pandemia por COVID-19, el costo de los alimentos se asocia con adherencia regular y mala a la DLG y con pobre CV(AU)


Coronavirus disease (COVID-19) is highly contagious and dynamic confinement measures have shown to significantly reduce the number of infections, however, they can alter the availability of food, affecting adherence to a gluten-free diet (GFD) and quality of life (QoL) in celiac disease (CD). The objective of this study was to evaluate the limiting factors, adherence to a gluten-free diet and quality of life in people with celiac disease in a COVID-19 pandemic period. Methods. On-line surveys were applied regarding adherence to the GFD, CV, and factors that have generated difficulty in carrying out a GFD in this setting. Results. 216 surveys of celiac patients over 15 years of age were analyzed, of which 91% were women with an average age of 36 + 10.7 years and with 5.8 + 6.0 years of the disease. 56.48% had excellent adherence to the GFD and 43.52% had a good QoL. The high cost of gluten-free foods was the question with the highest response percentage, associated with regular and poor adherence to the GFD (p-value = 0.001) and with poor QoL (p-value = 0.023). Conclusion. In a COVID-19 pandemic period, the cost of food is associated with regular and poor adherence to the GFD and with poor QoL(AU)


Subject(s)
Humans , Male , Female , Adult , Quality of Life , Celiac Disease/diet therapy , Diet, Gluten-Free , Treatment Adherence and Compliance , COVID-19/prevention & control , Celiac Disease/economics , Quarantine , Cross-Sectional Studies , Costs and Cost Analysis , Diet, Gluten-Free/economics , COVID-19/economics
2.
Arch. argent. pediatr ; 118(2): e188-e190, abr. 2020. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1100470

ABSTRACT

La invaginación intestinal es la causa más frecuente de obstrucción intestinal entre los 6 y los 36 meses de edad. La mayoría son idiopáticas. Se ha descrito la asociación entre la enfermedad celíaca y la invaginación intestinal en la población pediátrica. Se presenta el caso de un varón de 23 meses ingresado por estancamiento ponderal en cuyo estudio ecográfico se observaron invaginaciones íleo-ileales asintomáticas repetidas.


Intestinal intussusception is the most frequent cause of intestinal obstruction between 6 and 36 months of age, the majority being idiopathic. The association between celiac disease and intestinal intussusception in the pediatric population has been described. We present the case of a 23-month-old male admitted due to a failure to thrive. In his ultrasound study recurrent asymptomatic ileo-ileal invaginations were found


Subject(s)
Humans , Male , Infant , Celiac Disease/diagnosis , Intussusception/diagnostic imaging , Celiac Disease/diet therapy , Failure to Thrive , Diet, Gluten-Free , Intussusception/diet therapy
3.
Rev. chil. pediatr ; 90(6): 632-641, dic. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1058194

ABSTRACT

INTRODUCCIÓN: La dieta libre de gluten (DLG) de por vida es el tratamiento de la enfermedad celiaca (EC). Sien do una dieta restrictiva, impone limitaciones en la vida diaria y puede repercutir en la calidad de vida relacionada a la salud (CVRS). Nuestro objetivo fue evaluar la CVRS de pacientes celíacos en DLG, la concordancia entre pacientes-cuidador/a, y comparar la situación local con experiencias internacionales. PACIENTES Y MÉTODO: Se evaluaron pacientes de 8-18 años en DLG > 6 meses (37 diadas). Se les aplicó el "Celiac Disease Dutch Questionnaire" (CDDUX), que evalúa en 2 cuestio narios (uno al niño y otro al cuidador/padre), tres áreas: i) el tener EC, ii) la comunicación con otros y iii) la dieta. Se evaluó la confiabilidad, la dimensionalidad, y la consistencia interna mediante el coeficiente de Cronbach. RESULTADOS: Más del 50% de los pacientes y cuidadores reportan bien/ muy bien en las sub-escalas "tener enfermedad" y "dieta libre de gluten"; "comunicación" mostró altos porcentajes de mal/muy mal. No hubo diferencias significativas en la CVRS percibida por pacientes y cuidadores (global y sub-escala). Sí las hubo al analizar las respuestas de las/los cuida dores, que asignaron mejores puntajes a los pacientes varones (p = 0,022) y a quienes seguían DLG de manera no estricta (p = 0,049). La concordancia entre pacientes y cuidadores fue 39,2%. DISCUSIÓN: La CVRS de los pacientes evaluados aparece como satisfactoria, de las mejores reportadas en latinoamericana. El manejo de "tener EC" y la necesidad de mantener una "DLG" influyen menos en la CVRS que el tener que comunicarse con otros acerca de la enfermedad. La concordancia encontrada sugiere que la percepción del cuidador/a no refleja necesariamente lo que percibe el paciente.


INTRODUCTION: The lifelong gluten-free diet (GFD) is the treatment of celiac disease (CD). Being a restrictive diet, it limits daily life and can impact on the health-related quality of life (HRQoL). Our objective was to assess HRQoL of celiac patients on a GFD, the concordance between patients - caregivers, and to compare the local results with international data. PATIENTS AND METHOD: Patients aged 8-18 years on a GFD for >6months (37 dyads) were evaluated. The "Celiac Disease Dutch Questionnaire" (CDDUX) was applied, which evaluates in two questionnaires (one applied to the child and another one to the caregiver/parent), three areas: i) having CD, ii) communication with others, and iii) the diet. Reliability, dimensionality, and internal consistency were assessed using the Cronbach coefficient. RESULTS: More than 50% of patients and caregivers reported "well/very well" on sub-scales "having CD" and "GFD"; "communication" showed high percentages of "bad/very bad". Although there were no significant differences in HRQoL (global and subscale) perceived by patients and caregivers, there were when analyzing the answers of caregivers, who assigned better scores to boys (p=0.022) and to patients maintaining a non-strict GFD (p=0.049). Concordance between patients and caregivers was 39.2%. DISCUSSION: HRQoL of the assessed celiac children was satisfactory, among the best repor ted in Latin America. "Having CD" and the need for a "GFD" have less influence on HRQoL than "communication" with others about the disease. The concordance found suggests that the caregivers' perception does not necessarily reflect what patients perceive.


Subject(s)
Humans , Male , Female , Child , Adolescent , Quality of Life , Celiac Disease/diet therapy , Health Surveys , Diet, Gluten-Free/psychology , Celiac Disease/psychology , Chile , Cross-Sectional Studies , Caregivers
4.
Rev. pesqui. cuid. fundam. (Online) ; 11(3): 809-815, abr.-maio 2019. tab
Article in English, Portuguese | LILACS, BDENF | ID: biblio-987324

ABSTRACT

Objective: The study's purpose has been to further understand the repercussions that Celiac Disease has on the adults' life quality. Methods: It is an integrative literature review, which has used the following databases for the selection of articles published between 2006 and 2017: LILACS, VHL, SciELO, MEDLINE, CINHAL and CAPES periodic portal. Results: Twenty articles were fully scrutinized. Based on the content analysis stages, the following three categories appeared: Eating practices of adults bearing the Celiac Disease; Quality of life of the Celiac Disease bearing adult; Importance of the patient care team in the diagnosis and follow-up of adults bearing the Celiac Disease. Conclusion: It is expected that science finds other means of treatment, in addition to the restrictive diet and/or the fact that the industry may adapt to the needs of adult subjects, by offering quality products and low cost, for inclusive and sociable access, then reducing the suffering generated by the disease


Objetivo: Compreender as repercussões que a Doença Celíaca acarreta na qualidade de vida do sujeito adulto, por meio de uma revisão integrativa. Método: Revisão integrativa, com buscas nas bases de dados LILACS, BVS, SciELO, MEDLINE, CINHAL e portal de periódicos CAPES, com seleção de artigos publicados entre 2006 e 2017.Resultados: Foram analisados 20 artigos ao final na íntegra. Pautada nas etapas de análise de conteúdo, três categorias emergiram: Práticas alimentares do adulto com Doença Celíaca; Qualidade de vida do adulto com Doença Celíaca; Importância da equipe multiprofissional de saúde no diagnóstico e acompanhamento do adulto com Doença Celíaca. Conclusão: A perspectiva de que a ciência encontre outros meios de tratamento, além da dieta restritiva e/ou a indústria se adeque às necessidades dos sujeitos adultos, por meio da oferta de produtos de qualidade e baixo custo, para o acesso inclusivo e sociável, diminuindo o sofrimento gerado pela doença


Objetivo: Comprender las repercusiones que la Enfermedad Celíaca acarrea en la calidad de vida del sujeto adulto, por medio de una revisión integrativa. Método: La revisión integrativa, con búsquedas en las bases de datos LILACS, BVS, SciELO, MEDLINE, CINHAL y portal de revistas CAPES, con selección de artículos publicados entre 2006 y 2017. Resultados: Se analizaron 20 artículos al final en su totalidad. En las etapas de análisis de contenido, tres categorías emergieron: Prácticas alimentarias del adulto con enfermedad celíaca; Calidad de vida del adulto con enfermedad celiaca; Importancia del equipo multiprofesional de salud en el diagnóstico y acompañamiento del adulto con enfermedad celíaca. Conclusión: La perspectiva de que la ciencia encuentre otros medios de tratamiento, además de la dieta restrictiva y / o la industria se adecue a las necesidades de los sujetos adultos, a través de la oferta de productos de calidad y bajo costo, para el acceso inclusivo y sociable, disminuyendo el sufrimiento generado por la enfermedad


Subject(s)
Humans , Male , Female , Adult , Quality of Life , Celiac Disease/diet therapy , Celiac Disease/therapy , Patient Care Team/trends , Patient Care Team/statistics & numerical data , Diet, Gluten-Free
5.
São Paulo; s.n; s.n; 2019. 92 p. graf, tab, ilus.
Thesis in Portuguese | LILACS | ID: biblio-1048744

ABSTRACT

Os produtos sem glúten vêm aumentando sua participação no mercado atual, direcionados a uma população com restrição alimentar, como no caso da doença celíaca. Para segurança destes consumidores, foi criada uma legislação tratando das informações contidas nos rótulos, como as alegações relativas à presença ou não de glúten nos produtos. No entanto, a alegação "NÃO CONTÉM GLÚTEN" é informação útil à indústria, no contexto de seu marketing nutricional e, assim, como um elemento de sua estratégia de concorrência. O objetivo dessa pesquisa foi avaliar o impacto do marketing nutricional de alimentos sem glúten industrializados na rotulagem, sobre as escolhas alimentares de consumidores leigos, sem doença celíaca. Por meio de uma pesquisa qualitativa descritiva utilizando o método do Discurso do Sujeito Coletivo, concluiu-se que mais de 50% dos participantes recrutados seguem uma dieta livre de glúten motivados pela crença de ser saudável e auxiliar na manutenção do peso corpóreo. Estas motivações contrapõem-se à análise dos rótulos de produtos sem glúten industrializados que, apesar de estarem em conformidade com a LF 10.674/2003, são produtos, em sua maioria, ricos em carboidratos, com elevada densidade energética e sódio, cujos preços variam de 2 a 16 vezes mais que os produtos tradicionais similares. Grande parte das informações obtidas pelos participantes advém de meios virtuais como a internet e redes sociais, que promovem informação equivocada por meio de um marketing nutricional virtual que se aproveita de mitos envolvendo o glúten. Com os resultados dessa pesquisa, propõe-se o aumento de ações que visem informar corretamente a população brasileira sobre o assunto e o aprimoramento da legislação vigente determinando especificamente o local e o formato da informação básica sobre o glúten na rotulagem


Gluten-free products are increasing their share in the current market, targeting a population with food restriction, as in the case of celiac disease. For the safety of these consumers, legislation has been introduced dealing with information on labels such as claims regarding the presence or absence of gluten in products. However, the "GLUTEN FREE" claim is useful information to the industry in the context of its nutritional marketing and thus as an element of its competitive strategy. The objective of this research was to evaluate the impact of nutritional marketing of gluten-free foods by labeling processing on the food choices of lay consumers without celiac disease. Through a descriptive qualitative research using the Collective Subject Discourse method, it was concluded that more than 50% of the recruited participants follow a gluten-free diet motivated by the belief of being healthy and assisting in maintaining body weight. These motivations contrast with the analysis of processed gluten-free product labels which, while complying with LF 10.674/2003, are mostly carbohydrate-rich, high-calorie and sodium products, the prices of which vary. 2 to 16 times more than similar traditional products. Much of the information obtained by participants comes from virtual media such as the internet and social networks, which promote misinformation through virtual nutritional marketing that takes advantage of gluten myths. With the results of this research, it is proposed to increase actions aimed at correctly informing the Brazilian population about the subject and the improvement of current legislation, specifically determining the location and format of basic information on gluten in the labeling


Subject(s)
Marketing/instrumentation , Glutens/analysis , Celiac Disease/diet therapy , Food Labeling/legislation & jurisprudence
6.
Acta bioquím. clín. latinoam ; 52(4): 417-422, dic. 2018. graf
Article in Spanish | LILACS | ID: biblio-1001065

ABSTRACT

La enfermedad celíaca (EC) es una condición inflamatoria crónica del intestino delgado causada por intolerancia al gluten. El tratamiento consiste en la dieta libre de gluten (DLG). Los anticuerpos anti Saccharomyces cerevisiae (ASCA) están dirigidos contra la pared celular de la levadura, se asocian a enfermedades autoinmunes, y se propone la permeabilidad intestinal alterada como causa de activación de la inmunidad humoral. El objetivo del trabajo fue determinar la prevalencia de ASCA IgG e IgA en pacientes celíacos bajo tratamiento y evaluar la asociación de ASCA con el grado de adherencia a la DLG. Se analizaron 59 sueros de pacientes adultos celíacos con alta o baja adherencia a la DLG, y se determinó ASCA IgG e IgA. Se halló una prevalencia de ASCA IgG y/o IgA del 44%. Se encontró asociación entre ASCA-IgG y adherencia a DLG (OR 4,04 IC 95%: 1,32-12,38). La prevalencia de ASCA en la población celíaca estudiada es similar a la reportada en la bibliografía. La menor prevalencia de ASCA IgG en pacientes con una estricta DLG respecto de aquellos con baja adherencia, indicaría que su presencia depende del nivel de ingesta de gluten, sugiriéndolos como herramienta complementaria en el seguimiento del paciente celíaco.


Celiac disease (CD) is a chronic inflammatory condition of the small intestine caused by gluten intolerance. The treatment consists of gluten free diet (GFD). Anti Saccharomyces cerevisiae antibodies (ASCA) are directed against the cell wall of yeast, associated with autoimmune diseases, and an altered intestinal permeability is proposed as a cause of activation of humoral immunity. The objective of this work was to determine the prevalence of IgG and IgA ASCA in celiac patients under treatment and to evaluate the association of ASCA with the degree of adherence to GFD. Fifty-nine serum samples from adult celiac patients with high or low adherence to GFD were analyzed, determining IgG and IgA ASCA. A 44% prevalence of IgG and/or IgA ASCA was found. An association was discovered between IgG ASCA and GFD adherence (OR 4.04, 95% CI: 1.32-12.38). The prevalence of ASCA in the studied celiac population is similar to that reported in the literature. The lower prevalence of IgG ASCA in patients with a strict GFD compared to those with low adherence would indicate that their presence depends on the level of gluten intake, suggesting them as a complementary tool in the follow-up of the celiac patient.


A doença celíaca (DC) é uma condição inflamatória crônica do intestino delgado causada pela intolerância ao glúten. O tratamento consiste na dieta sem glúten (DSG). Os anticorpos anti Saccharomyces cerevisiae (ASCA) são dirigidos contra a parede celular da levedura, associados a doenças autoimunes, e à permeabilidade intestinal alterada como causa da ativação da imunidade humoral. O objetivo foi determinar a prevalência de ASCA IgG e IgA em pacientes celíacos em tratamento; avaliar a associação de ASCA com o grau de adesão ao DSG. Foram analisados 59 soros de pacientes celíacos adultos com alta ou baixa adesão ao DSG, determinando ASCA IgG e IgA. Foi encontrada uma prevalência de SCA IgG/ou IgA de 44%. Foi encontrada uma associação entre ASCA-IgG e a adesão ao DSG (OR 4,04 IC 95% 1,32-12,38). A prevalência de ASCA na população celíaca estudada é semelhante à relatada na literatura. A menor prevalência de ASCA IgG em pacientes com rigorosa DSG, em comparação àqueles com baixa adesão, indicaria que sua presença depende do nível de ingestão de glúten, sugerindo-os como uma ferramenta complementar no seguimento do paciente celíaco.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Saccharomyces cerevisiae/immunology , Celiac Disease/diet therapy , Celiac Disease/microbiology , Diet, Gluten-Free , Treatment Adherence and Compliance , Antibodies, Fungal/blood , Immunoglobulin A/immunology , Immunoglobulin G/immunology , Prevalence , Cross-Sectional Studies , Cohort Studies
7.
Rev. chil. pediatr ; 89(2): 216-223, abr. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-900090

ABSTRACT

INTRODUCCIÓN: La enfermedad celíaca (EC) es una enteropatía crónica mediada inmunológicamente que afecta ~1% de la población. La dieta libre de gluten (DLG) es su único tratamiento y la principal limitante de su eficacia es la falta de adherencia. OBJETIVOS: Evaluar factores que influyen en la adherencia a la DLG de pacientes celiacos pediátricos. Medir la concordancia entre la serología y un cuestionario nutricional de adherencia. PACIENTES Y MÉTODO: Estudio transversal en celiacos menores de 18 años, en DLG por más de 6 meses. Se aplicó un cuestionario con 5 grupos de factores (OMS). Se registraron características clínicas, dieta de los últimos 3 meses, percepción (de padres/cuidadores, y del paciente adolescente) de la DLG; el conocimiento de los alimentos permitidos y disponibles en el país de la simbología "libre de gluten", y si lee/no lee ingredientes de un alimento antes de comprarlo. Se aplicó un score dando un punto a cada respuesta correcta (0-4). A un subgrupo se le aplicó el cuestionario de adherencia a la DLG de Biagi. Se midió EMA y TTG dentro de las 2 semanas posteriores a la entrevista. Se usó índice Kappa para evaluar la concordancia entre TTG y encuesta nutricional de adherencia; Chi cuadrado para la asociación entre los factores evaluados y los resultados de EMA y TTG, y Odds ratio como medida de asociación. Se aplicó un modelo de regresión logística a los factores asociados a los resultados de los exámenes de anticuerpos EMA y TTG (positivo-negativo). Se definió "buena adherencia a la DLG" cuando EMA y TTG fueron negativos. Resultados: De 65 pacientes; 44% y 30,1% adherían correctamente a la DLG según medición de anticuerpos (TTG y EMA) y el cuestionario, respectivamente. La "edad de inicio de la enfermedad" (p = 0,049), "percepción de estar realizando bien la DLG" (p = 0,002) y la "conducta del paciente frente a alimentos en reuniones sociales" (p = 0,005), se asociaron significativamente con adherencia a DLG. Hubo concordancia entre los exámenes serológicos y el cuestionario de adherencia (p = 0,0001). DISCUSIÓN: La adherencia fue menor que la reportada en la literatura. La intervención de variables asociadas a adherencia identificadas, podría ayudar al mejor seguimiento de los pacientes, especialmente en aquellos quienes por diversos motivos no puedan realizarse exámenes serológicos con la frecuencia adecuada.


INTRODUCTION: Celiac disease (CD) is a chronic immune-mediated enteropathy present in ~1% of population. Gluten-free diet (GFD) is the only treatment for this condition and the main limitation of its efficacy is the lack of adherence. OBJECTIVE: To assess factors influencing adherence to GFD in pediatric patients and measure the concordance between serological results and a nutritional adhe rence questionnaire. PATIENTS AND METHODS: celiac patients younger than 18 years of age, diagnosed CD following ESPGHAN criteria, on GFD for at least 6 months and consulting at Hospital Roberto del Río, Santiago, in 2008-2016, were assessed. Clinical presentation, nutritional evaluation and fac tors related to adherence to treatment (diet) were registered. A subsample answered Biaggi's nutri tional questionnaire. RESULTS: Of 65 evaluated patients, 44% and 30,1% adhered to GFD according to blood autoantibodies (TTG and EMA) and the adherence questionnaire, respectively. "Age at debut" (p = 0.049), "perception of following GFD correctly" (p = 0.002) and "behavior in social events" (p = 0.005) were significantly associated with adherence to GFD. There was concordance between serological test and Biagi's questionnaire (p = 0.0001). DISCUSSION: Adherence to GFD was lower than reported in literature. Intervention of some of the identified variables associated with adherence may help improving follow-up of celiac patients, especially those that due to diverse situations cannot measure their antibodies periodically.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Perception , Celiac Disease/diet therapy , Health Knowledge, Attitudes, Practice , Patient Compliance , Diet, Gluten-Free/psychology , Celiac Disease/diagnosis , Celiac Disease/psychology , Cross-Sectional Studies
8.
Mem. Inst. Invest. Cienc. Salud (Impr.) ; 16(1): 64-70, abr. 2018. tab
Article in Spanish | LILACS, BDNPAR | ID: biblio-997765

ABSTRACT

La Ley 20.830/98 reglamenta el enriquecimiento de la harina, sin embargo, no contempla a la premezcla de harinas aptas para celíacos. Aproximadamente 50% de los celíacos presenta anemia, por lo es necesario elaborar productos cuyas características nutricionales, sensoriales y funcionales sean óptimas. El objetivo del trabajo fue enriquecer con hierro y vitaminas del complejo B (mix) la premezcla de harinas apta para celíacos y evaluar la aceptabilidad de dos panificados de alta demanda poblacional elaborados a partir de la premezcla. En cocinas especializadas para celíacos se elaboraron panes y palitos, cada uno en dos versiones (con mix y sin mix), se presentaron en envases individuales y etiquetados forma numérica para la degustación. Se evaluó la aceptabilidad de los panificados utilizando una escala hedónica de 9 puntos a través de un cuestionario autoadministrado. Se utilizó la prueba t de Student para la comparación de promedios obtenidos. Participaron 105 celíacos (81% mujeres), el promedio de edad fue 34,5±10,9 años Según auto-reporte el 60% cursó con anemia. La puntuación global promedio de aceptabilidad fue: pan sin mix 7,42±1,33puntos; pan con mix 8,00±1,06 puntos; palito sin mix 7,91±1,05 puntos y palito con mix 7,86±1,17 puntos. Se realizó el análisis de la premezcla apta para celíacos y se constató que la misma cumple con el aporte de micronutrientes (hierro, B1, B2, B3 y ácido fólico). En este estudio, los panes con mix tuvieron mayor aceptabilidad que aquellos sin mix. En el caso de los palitos no se observaron diferencias en la aceptabilidad entre productos (con mix vs sin mix)(AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Vitamin B Complex/therapeutic use , Food, Fortified , Celiac Disease/diet therapy , Iron, Dietary/therapeutic use , Flour , Iron Deficiency/therapy , Bread , Cross-Sectional Studies , Flour Benefactor
9.
Arq. gastroenterol ; 55(1): 86-93, Apr.-Mar. 2018. tab, graf
Article in English | LILACS | ID: biblio-888239

ABSTRACT

ABSTRACT BACKGROUND: Celiac disease is an immune-mediated disorder with a multiform presentation and therefore a challenging diagnosis. OBJECTIVE: Our purpose is to identify the epidemiological, clinical, laboratory and histologic characteristics of children with celiac disease at diagnosis and on follow-up. METHODS: Children with previously established or newly diagnosed celiac disease, admitted in a tertiary centre in a two-year period (2014-2016) were recruited. Data was collected retrospectively from electronic medical records and clinical notes, and subsequently analysed with SPSS version 20.0. RESULTS: A total of 159 patients, out of 312, were included. Age ranged from 1 to 17 years (mean ± SD: 8.5±4.5 years, 69% girls). Disease presentation was classical in 60%, non-classical in 25%, subclinical in 10% and 5% classified as potential celiac disease. Non-classical and subclinical profiles had a higher mean age at presentation but not statistically significant (P-value 0.24). The most frequent gastrointestinal features at presentation were abdominal pain (58%), diarrhea (43%) and bloating (27%). A positive family history for celiac disease was present in 24% (n=35). We found anaemia in 23%, low ferritin in 63% and a moderate to severe deficiency of 25-hydroxyvitamin D in 62%. celiac disease -specific serologic testing and esophagogastroduodenoscopy were performed in 99%. Histology revealed modified Marsh 2 or 3 enteropathy in 94%, the remaining had normal histology but positive human leukocyte antigen typing. Clinical improvement at 12 months of gluten-free diet was complete in 51% and partial in 49%. IgA tTG normalized after 12-30 months of gluten-free diet in 45%. On growth assessment at diagnosis and after 12-28 months of gluten-free diet, 100% had height increase (mean ±SD: 7.11±4.43 cm) and 96% weight gain (mean ±SD: 5.60±4.91 kg). CONCLUSION: Our findings outline the diverse clinical presentations of pediatric celiac disease that should be considered irrespective of age. Increased clinician's awareness will enable an early diagnosis and treatment, with subsequent symptom and nutritional status improvement.


RESUMO CONTEXTO: A doença celíaca é uma doença imuno-mediada com uma apresentação multiforme constituindo, por isso, um desafio diagnóstico. OBJETIVO: O objetivo deste trabalho foi identificar as características epidemiológicas, clínicas, laboratoriais e histológicas ao diagnóstico e no seguimento de crianças com doença celíaca. MÉTODOS: Foram incluídas crianças com doença celíaca admitidas num hospital pediátrico terciário ao longo de 2 anos (2014-2016). A recolha da informação clínica foi retrospetiva a partir dos processos clínicos eletrônicos ou em papel e analisada com o software SPSS versão 20.0. RESULTADOS: Foram incluídos 159 doentes, a partir de uma amostra de 312. A idade variou entre 1 e 17 anos (média ± desvio padrão: 8,5±4,5 anos, 69% do sexo feminino). A apresentação da doença foi clássica em 60%, não clássica em 25%, subclínica em 10% e classificada como doença celíaca potencial em 5%. Os doentes com apresentações não clássica e subclínica, tiveram uma idade média de apresentação superior, mas sem significância estatística (P=0,24). Ao diagnóstico, as manifestações gastrointestinais mais frequentes foram dor abdominal (58%), diarreia (43%) e distensão abdominal (27%). Havia história familiar de doença celíaca em 24% (n=35) dos doentes. Foi detetada anemia em 23%, níveis baixos de ferritina em 63% e um défice moderado a grave de 25-hidroxivitamina D em 62%. Foram realizados testes serológicos para a doença celíaca e a esofagogastroduodenoscopia em 99%. Os achados histológicos revelaram enteropatia nos estágios de Marsh modificado tipo 2 ou 3 em 94%, os restantes apresentavam histologia normal mas tipagem do antigénio leucocitário humano positiva. Aos 12 meses de dieta sem glúten a melhoria clínica foi completa em 51% e parcial em 49%. O valor de IgA tTG normalizou em 45% após 12-30 meses de dieta sem glúten. Na avaliação do crescimento, ao diagnóstico e após 12-28 meses de dieta sem glúten, 100% teve evolução estatural positiva (média ±DP: 7,11±4,43 cm) e 96% aumentaram de peso (média ±DP: 5,60±4,91 kg). CONCLUSÃO: Os resultados do estudo evidenciam a diversidade da apresentação clínica da doença celíaca em pediatria, devendo ser considerada em todas as idades. Um maior reconhecimento da doença pelos médicos permitirá um diagnóstico e tratamento atempados, com subsequente melhoria sintomática e do estado nutricional.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Celiac Disease/diagnosis , Diet, Gluten-Free , Serologic Tests , Celiac Disease/diet therapy , Celiac Disease/blood , Mass Screening , Retrospective Studies , Follow-Up Studies , Tertiary Care Centers , Hospitals, Pediatric
10.
In. Reichenbach, Juan Alberto. La hora de oro en pediatría. La Plata, Femeba, 2018. p.241-253.
Monography in Spanish | LILACS | ID: biblio-1052425

ABSTRACT

Se intentan aclarar los conceptos diferenciales de enfermedad celíaca, sensibilidad al gluten no celíaca y alergia al trigo. Se abordan las manifestaciones clínicas junto al Score clínico desarrollado en el Servicio para calcular matemáticamente la presencia de enfermedad celíaca. Finalmente, se aborda el tartamiento, seguimiento, y las nuevas patologías relacionadas a la enfermedad


Subject(s)
Humans , Child, Preschool , Child , Celiac Disease , Celiac Disease/diet therapy , Wheat Hypersensitivity , Celiac Disease/classification , Celiac Disease/therapy
11.
Rev. chil. pediatr ; 88(3): 417-423, jun. 2017. tab
Article in Spanish | LILACS | ID: biblio-899997

ABSTRACT

El gluten y otras proteínas relacionadas del trigo, centeno y cebada, tienen propiedades antigénicas que pueden desencadenar reacciones adversas en individuos susceptibles. La enfermedad celíaca fue la primera patología en que se estableció relación causal con estas proteínas alimentarias. Recientemente se han descrito la alergia al trigo y la sensibilidad no celíaca al gluten. Si bien sus formas de presentación clínica y su relación con la ingesta pueden ser similares, sus mecanismos patogénicos, forma de diagnóstico y tratamiento difieren. Dado que su prevalencia en conjunto es relativamente alta, resulta necesario que los médicos de atención primaria y pediatras se familiaricen con estas patologías, sepan cómo diferenciarlas y enfrentarlas. El objetivo de esta revisión es comparar los principales aspectos de epidemiología, fisiopatología, diagnóstico y tratamiento de estas 3 condiciones.


Gluten and other related proteins of the wheat, rye and barley, have antigenic properties that may trigger adverse reactions in susceptible individuals. Celiac disease was the first pathology with clear causal association related to the intake of these proteins. Recently, wheat allergy and non celiac gluten sensitivity have been described. Although, clinical presentation and its relation with protein ingestion may be similar and elicit confusion, their pathogenic mechanism, diagnosis and treatment are quite different. Since the prevalence of these diseases is relatively high as a whole, it is essential that these become familiar to primary care doctors and general pediatricians, thus they will know how to differentiate and face them. The aim of this review is to compare the main aspects of epidemiology, pathofisiology, diagnosis and treatment of these 3 conditions.


Subject(s)
Humans , Celiac Disease/diagnosis , Celiac Disease/diet therapy , Celiac Disease/physiopathology , Celiac Disease/epidemiology , Wheat Hypersensitivity/diagnosis , Glutens/adverse effects , Prognosis , Chile/epidemiology , Global Health , Wheat Hypersensitivity/diet therapy , Wheat Hypersensitivity/physiopathology , Wheat Hypersensitivity/epidemiology , Diagnosis, Differential , Diet, Gluten-Free
12.
Reprod. clim ; 32(2): 120-126, 2017. ilus, tab
Article in Portuguese | LILACS | ID: biblio-883428

ABSTRACT

Objetivo: Revisar os dados já publicados sobre a associação entre doença celíaca materna e desfechos gestacionais desfavoráveis (nascimento de recém­nascidos com baixo peso, prematuros e pequenos para idade gestacional) e sua relação com a dieta isenta em glúten. Fontes dos dados: Revisão sistemática feita nas bases de dados do PubMed e da Biblioteca Virtual em Saúde. Incluídos estudos de coorte que compararam a incidência de desfechos gestacionais desfavoráveis em mulheres com doença celíaca tratadas e não tratadas com dieta isenta em glúten. A validade interna dos estudos foi avaliada pelos critérios Strobe. Síntese dos dados: Doença celíaca materna não tratada esteve associada ao nascimento de recém­nascidos de baixo peso, prematuros e pequenos para a idade gestacional. Quando tratada, o risco desses desfechos se aproximou do encontrado na população sem doença celíaca. Conclusões: Doença celíaca materna não tratada esteve associada a desfechos gestacionais desfavoráveis. A dieta isenta em glúten parece aproximar o risco desses desfechos ao encontrado em mulheres saudáveis.(AU)


Aim: To review the published data on the association between maternal celiac disease and adverse pregnancy outcomes and its relationship to gluten­free diet. Sources: A systematic review of Biblioteca Virtual em Saúde (LILACS, IBECS, MEDLINE, SciELO, and Cochrane) and PubMed databases was performed. Cohort studies that compared the incidence of adverse pregnancy outcomes in women with treated and untreated celiac disease were included in the analysis. STROBE criteria was used to assess the internal validity of the studies. Summary of the findings: Maternal untreated celiac disease was associated with premature births, low birthweight and small for gestational age. When celiac disease was treated, the risk of these outcomes was similar that found in people without celiac disease. Conclusions: Untreated maternal celiac disease was associated with adverse pregnancy outcomes. Treatment with gluten­free diet reduced significantly the risk of these outcomes, making the rate similar to that observed on women without celiac disease.(AU)


Subject(s)
Humans , Female , Celiac Disease/complications , Celiac Disease/diet therapy , Diet, Gluten-Free/statistics & numerical data , Pregnancy Outcome
13.
Rev. chil. pediatr ; 87(6): 442-448, Dec. 2016. tab
Article in Spanish | LILACS | ID: biblio-844563

ABSTRACT

La enfermedad celíaca (EC) es un trastorno sistémico inmune mediado por la ingesta de gluten en individuos genéticamente susceptibles. Se caracteriza por manifestaciones clínicas variables, auto anticuerpos anti-endomisio, anti-transglutaminasa (tTG) y/o anti-péptidos de gliadina deamidados (PGD) en sangre, más daño variable de la mucosa intestinal. En Chile el 0,76% de los mayores de 15 años tiene IgA-tTG positiva y la prevalencia de EC se estima en ~0,6%. En familiares de primer grado de celíacos se ha identificado ~17% de casos tTG positivos. Hasta hoy el único tratamiento es la dieta libre de gluten (DLG), que para ser efectiva debe ser estricta, permanente y durante toda la vida. La DLG no contiene cero gluten, sino que lo disminuye hasta un «punto de corte¼, que en Chile es 3 ppm (o mg/kg de producto). La mortalidad de la EC es mayor que la de la población general, y la falta de adherencia al tratamiento se asocia a complicaciones (procesos autoinmunes y cáncer principalmente). La DLG es difícil de mantener estrictamente, y las transgresiones son por lejos la principal causa de falta de respuesta al tratamiento. El seguimiento también es difícil, porque no existen marcadores objetivables que midan la adherencia. En la práctica clínica se utiliza la medición de auto anticuerpos anti-endomisio, tTG y/o PGD; más recientemente se están evaluando las entrevistas por una nutricionista especializada, cuestionarios validados y la medición de péptidos 33-mer en heces como alternativas o complementos de la evaluación de adherencia. En este artículo se revisan las herramientas de seguimiento actualmente utilizadas, poniendo énfasis en aquellas disponibles en Chile.


Coeliac disease (CD) is a systemic autoimmune disorder triggered by gluten consumption in genetically susceptible individuals. It exhibits several clinical features, such as blood auto-antibodies (anti-endomysial antibodies EMA, anti-transglutaminase antibodies tTG, anti-deamidated gliadin peptides PGD), plus variable degrees of damage in the small intestinal mucosa. In Chile, tTG is positive in 0.76% in individuals >15 years, with the prevalence of CD being estimated at 0.6%. Approximately17% of first-degree relatives of coeliac patients have been reported tTG positive. To date, the gluten free diet (GFD) is the only known treatment for CD. To be effective, this must be lifelong, permanent, and strict. Gluten content in the GFD is not zero, but is limited to a cut-off of 3 ppm (or mg/kg of product) in Chile. Mortality higher than that of the general population has been reported among coeliac patients, and poor adherence to GFD is associated with complications (mainly autoimmune processes and cancer). GFD is difficult to maintain strictly and poor adherence is by far the main cause of lack of response to treatment. Follow-up of adherence is also difficult because there are no objective measurements to assess it. In clinical practice determination of serum EMA, tTG and PGD is routinely used for these purposes, although more recently, the interview by an expert dietitian, validated questionnaires and measurement of faecal 33-mer peptide are being assessed as alternatives or complements to measure adherence to GFD. A review is presented with the current concepts on the available tools to follow up patients on GFD, emphasising those available in Chilel.


Subject(s)
Humans , Celiac Disease/diet therapy , Patient Compliance , Diet, Gluten-Free , Autoantibodies/analysis , Celiac Disease/immunology , Chile , Surveys and Questionnaires , Glutens/administration & dosage , Glutens/adverse effects
14.
Rev. Nutr. (Online) ; 29(6): 755-764, Nov.-Dec. 2016. tab, graf
Article in Spanish | LILACS | ID: biblio-830659

ABSTRACT

RESUMEN Objetivo: La celiaquía como enfermedad crónica tiene una alta prevalencia en nuestra sociedad. El artículo analiza los aspectos psicosociales de la enfermedad celíaca en los diferentes entornos, valorando el impacto de la implantación de una dieta estricta libre de gluten. Métodos: Estudio cualitativo entre los meses de Enero del 2013 a Abril del 2013 en el cual, a través de la teoría fundamentada y el análisis de contenido, se ha profundizado en el análisis de las entrevistas semiestructuradas a personas con enfermedad celíaca en España. Se realizaron llamamientos a traves de las redes sociales y grupos de celíacos hasta llegar a la saturación teórica, que determinó el tamaño final de la muestra de 24 personas. Resultados: Educación Sanitaria, Aislamiento social, soledad y desconocimiento social emergieron como categorías centrales en la experiencia de adopción de la dieta libre de gluten a partir del diagnóstico de celiaquía. Conclusión: Los profesionales deben promover y apoyar estrategias de apoyo social basadas en una comprensión íntegra de las experiencias de desarraigo y marginación que los pacientes celíacos experimentan en sus relaciones sociales a través de la comida. Se requiere un aumento de la educación sanitaria para entender e integrar el impacto psicosocial del diagnóstico de celiaquía y la dieta libre de gluten.


ABSTRACT Objective: Celiac disease is a chronic disease which has a high prevalence in our society. The aim of this paper is to explore the process of adapting the celiac in different social environments, assessing the impact of the implementation of a strict gluten-free diet. Methods: A qualitative study was carried out in the months of January 2013 to April 2013 through which the grounded theory and content analysis have deepened the analysis of semi-structured interviews with people with celiac disease in Spain. Appeals via social networks and celiac groups were conducted in order to reach theoretical saturation, which determined the final sample size of 24 people. Results: Social isolation, loneliness and social ignorance are some of the categories that have emerged when we talk about celiac disease and the gluten-free diet. Conclusion: Professionals should promote and support social support strategies based on an integrated understanding of the experiences of displacement and marginalization that celiac patients experience in their social relationships through food. There should be increased health education to understand and integrate the psychosocial impact of the diagnosis of celiac disease and the gluten-free diet.


Subject(s)
Humans , Male , Female , Celiac Disease , Social Perception , Celiac Disease/diet therapy , Diet, Gluten-Free
15.
Rev. gaúch. enferm ; 37(1): e53787, 2016. graf
Article in Portuguese | LILACS, BDENF | ID: biblio-960713

ABSTRACT

RESUMO Objetivo Compreender a experiência de crianças e adolescentes que convivem com diabetes mellitus tipo 1 e doença celíaca. Método Estudo qualitativo, exploratório e descritivo. A coleta de dados ocorreu entre janeiro e setembro de 2012, com 3 crianças e 2 adolescentes, em um ambulatório de diabetes do Hospital das Clinicas da FMUSP ou na residência dos participantes na cidade de São Paulo, por meio de entrevistas semiestruturadas. Utilizou-se a Análise de Conteúdo como método de tratamento dos dados. Resultados A dieta aparece como foco da experiência dos participantes, porém com diferentes significados. As crianças têm dificuldade em seguir a dieta, enquanto os adolescentes referem que os aspectos sociais e afetivos são os mais afetados. Conclusão Reforça-se a importância do enfermeiro buscar estratégias em parceria com as crianças, os adolescentes e suas famílias a fim de minimizar as dificuldades encontradas principalmente no manejo da dieta imposta por ambas as doenças.


RESUMEN Objective Comprender la experiencia de los niños y adolescentes que viven con diabetes tipo 1 y la enfermedad celíaca. Método Estudio cualitativo exploratorio y descriptivo, se incluyeron 3 niños y 2 adolescentes; los datos fueron colectados de enero a septiembre de 2012, en la clínica de diabetes del Hospital de Clínicas de la Facultad de Medicina de la Universidad de São Paulo o en la residencia de los participantes en São Paulo, a través de entrevistas semi-estructuradas. Para el tratamiento de los datos se utilizó la técnica de Análisis de Contenido. Resultados La dieta es el foco de la experiencia de los participantes, pero con diferentes significados. Los niños tienen dificultad para seguir la dieta, mientras que los adolescentes reportan que los aspectos sociales y afectivos son los más afectados. Conclusión Los resultados refuerzan la importancia de la enfermera buscar estrategias en colaboración con los niños, adolescentes y sus familias para minimizar dificultades encontradas principalmente en la gestión de la dieta impuesta por ambas enfermedades.


ABSTRACT Objective To understand the experience of children and adolescents living with type 1 diabetes and celiac disease. Method This is a qualitative exploratory-descriptive study. The participants were 3 children and 2 adolescents. The data were collected by means of semi-structured interviews between January and September 2012 at the participant's residence or at the diabetic outpatient clinic of the Hospital das Clinicas, Faculty of Medicine, University of Sao Paulo in São Paulo, Brazil. The content analysis technique was used to process the data. Results The key aspect of the illness experience of the patients was their diet, but with different meanings. The children had difficulty following the diet, while the adolescents reported that they had greater difficulty coping with the social and affective aspects of their diet. Conclusion The results reinforce the importance of nurses who seek strategies, together with the patients and their families, that help minimize the difficulties of these patients, especially with regard to managing the diet imposed by both diseases.


Subject(s)
Humans , Male , Female , Child , Adolescent , Celiac Disease/psychology , Diabetes Mellitus, Type 1/psychology , Social Adjustment , Brazil , Adaptation, Psychological , Attitude to Health , Comorbidity , Celiac Disease/complications , Celiac Disease/diet therapy , Celiac Disease/nursing , Interviews as Topic , Patient Compliance , Qualitative Research , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/diet therapy , Diabetes Mellitus, Type 1/nursing , Diet, Diabetic/psychology , Emotions , Diet, Gluten-Free/psychology , Insulin/therapeutic use , Interpersonal Relations
16.
Arq. gastroenterol ; 52(3): 171-175, July-Sep. 2015. tab, ilus
Article in English | LILACS | ID: lil-762866

ABSTRACT

BackgroundRestrictions imposed by the gluten-free diet generate large changes in the daily habits of the celiac patient, causing a negative impact on quality of life.ObjetiveThis study aimed to evaluate the quality of life of patients with celiac disease on a capital in Southern Brazil.MethodsPatients older than 18 years were included, with confirmed celiac disease for at least 60 days in the period from June to October 2013. A validated questionnaire, with specific questions to assess the patient’s quality of life celiac was applied. A total score ranged from 20 to 100 points; the higher the score, worse quality of life.ResultsA total of 103 questionnaires were evaluated, 96 (93.2%) female, with average score 56.6±12.35 (28 to 88 points). The comparison between the questionnaire scores and family income was not significant (P=0.139). Patients diagnosed less than 1 year have poorer quality of life than those with more than 10 years (P=0.063). Patients older than 60 years had better quality of life compared with the younger ones (P=0.04).ConclusionThere was no association between quality of life and factors such as family income, length of diet and age at diagnosis. Chronological age greater than 60 years has positively influenced the quality of life of celiac patients.


ContextoRestrições impostas pela dieta isenta em glúten podem gerar grandes mudanças nos hábitos diários do paciente celíaco, causando um impacto negativo na sua qualidade de vida.ObjetivoEste estudo teve como objetivo avaliar a qualidade de vida de pacientes com doença celíaca, em uma capital do Sul do Brasil.MétodosPacientes maiores de 18 anos foram incluídos, com doença celíaca confirmada há mais de 60 dias, no período de junho a outubro de 2013. Um questionário validado, com perguntas específicas para avaliar a qualidade de vida do paciente celíaco foi aplicado. A pontuação total nesse questionário varia entre 20 a 100 pontos; quanto maior a pontuação, pior a qualidade de vida.ResultadosNo total 103 questionários foram avaliados, sendo 96 (93,2%) do sexo feminino, com pontuação média de 56,6±12,35 (28-88 pontos). A comparação entre os escores do questionário e renda familiar não foi significativa (P=0,139). Pacientes diagnosticados há menos de 1 ano, apresentam pior qualidade de vida do que aqueles com mais de 10 anos (P=0,063). Pacientes com mais de 60 anos apresentaram melhor qualidade de vida em comparação com os mais jovens (P=0,04).ConclusãoNão houve associação entre a qualidade de vida e fatores como renda familiar, tempo de dieta e idade no momento do diagnóstico. A idade cronológica superior a 60 anos influenciou positivamente a qualidade de vida de pacientes celíacos.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Celiac Disease/physiopathology , Quality of Life , Age Factors , Brazil , Cross-Sectional Studies , Celiac Disease/diet therapy , Diet, Gluten-Free , Socioeconomic Factors , Surveys and Questionnaires , Time Factors
17.
Rev. Méd. Clín. Condes ; 26(5): 613-627, sept. 2015. ilus, tab
Article in Spanish | LILACS | ID: biblio-1128561

ABSTRACT

La Enfermedad Celiaca (EC) tiene una prevalencia cercana al 1% de la población general y se considera que hay un número importante de pacientes asintomáticos no diagnosticados. Su presentación clínica es variable comprendiendo el clásico síndrome de malabsorción, formas menores y la EC silente. El diagnóstico serológico tiene una elevada sensibilidad y especificidad y siempre debe confirmarse con biopsia. El diagnóstico en pacientes en dieta libre de gluten incluye test de tipificación de HLA y prueba de dieta con gluten con estudio serológico e histológico posterior. El pilar del tratamiento es la dieta libre de gluten, que debe ser supervisada por un nutriólogo con experiencia. La monitorización de la terapia debe realizarse con serología. La EC mal controlada puede determinar complicaciones como linfoma y adenocarcinoma de intestino delgado. En el futuro es probable que nuevas terapias farmacológicas sean de utilidad en el manejo de la EC.


Celiac disease has a prevalence near to 1% of general population and there is an important amount of asymptomatic people not yet diagnosed. Clinical presentation includes the classical malabsorption syndrome, minor and silent celiac disease. Serologic diagnosis has an elevated sensitivity and specificity, and must be confirmed by biopsy. Diagnosis in those on gluten free diet includes HLA type and gluten challenge with posterior serologic and histologic evaluation. The core of the treatment is the gluten free diet that must be supervised by an expert nutritionist. Monitoring is with serology. Poor disease control can determine complications such as lymphoma and small bowel adenocarcinoma. In the future, it is likely that new pharmacologic therapies will be available for the management of celiac disease.


Subject(s)
Humans , Celiac Disease/diagnosis , Celiac Disease/etiology , Celiac Disease/therapy , Signs and Symptoms , Autoimmune Diseases/complications , Lymphoma, Non-Hodgkin/etiology , Histocompatibility Testing , Serologic Tests , Celiac Disease/classification , Celiac Disease/complications , Celiac Disease/diet therapy , Nutritional Status , Endoscopy, Gastrointestinal , Diet, Gluten-Free , Neoplasms/etiology
18.
Gastroenterology and Hepatology from Bed to Bench. 2015; 8 (2): 160-166
in English | IMEMR | ID: emr-178191

ABSTRACT

This study was aimed to evaluate symptomatic as well as histopathologic response to GFD in patients with gluten-sensitive enteropathies including celiac disease, lymphocytic duodenosis and non-specific duodenitis. Gluten-free diet [GFD] is the main treatment of celiac disease. However, its impact on other disorders of gluten sensitivity spectrum is less clear. In a prospective observational study in Modarres hospital Tehran, Iran, 35 patients with chronic manifestations including low BMI, diarrhea, greasy stool and bloating were evaluated using serology for anti-tTG, endoscopy and histopathology. Patients were categorized in three diagnostic groups accordingly including celiac disease [CD], lymphocytic doudenosis [LD] and non-specific duodenitis [NSD]. All patients were put on a GFD for 6 months, and subjective symptomatic response, serology, endoscopy and histopathologic tests were repeated and compared with baselines and among groups. Of the total 35 patients, 5 had CD [14.3%], 9 had LD [25.7%] and 21 [60%] had NSD. Bloating was the most common symptom followed by diarrhea. Majority of patients [80%] had low BMI. All symptoms alleviated following a GFD but bloating was the only significant one. A significant increase was found in total mean BMI [17.3+/-0.7 v.s. 17.9+/-0.9]. Histopathologic examination showed a complete resolution in 48.5% [n=17] patients, 10 in NSD group, 4 in LD group and 3 in CD group. Final prevalence of gluten-sensitive enteropathy [LD and NSD cases that responded to GFD] was 46.6%. GFD may have more implications other than celiac disease. Other gluten-sensitive enteropathies, like LD and NSD, might also respond to this treatment particularly in patients with low BMI


Subject(s)
Humans , Male , Female , Celiac Disease/diet therapy , Prospective Studies , Duodenitis
19.
20.
Arq. gastroenterol ; 51(2): 139-143, Apr-Jun/2014. tab, graf
Article in English | LILACS | ID: lil-713589

ABSTRACT

Context The ingestion of gluten is responsible for the symptoms of Celiac disease, but other environmental factors can also influence. Strains of the Bifidobacterium genus have been shown to afford protection against the inflammatory response and mucosal damage caused by gliadin peptides in vitro. Objectives This study was designed to compare the concentration of fecal bifidobacteria and pH of patients with celiac disease on gluten-free diet and control subjects in order to identify if the imbalance on fecal microbiota still remain during the treatment of celiac disease and identify the necessity of dietary supplementation with pre- or probiotics. Methods It was analyzed the feces of 42 healthy subjects and 14 celiac patients. The bifidobacteria count in feces was done in selective medium BIM-25. Microscopic analysis of the colonies was performed by Gram stain. The identification of the genus Bifidobacterium was performed by determination of fructose-6-phosphate phosphoketolase. Fecal pH was measured using a pH meter. Results The concentration of bifidobacteria per gram of feces was significantly higher in healthy subjects (controls) (1.5 ± 0.63 x108 CFU/g) when compared to celiac patients (2.5 ± 1.5 x107 CFU/g). The fecal pH was not different between celiac patients (7.19 ± 0.521) and controls (7.18 ± 0.522). Conclusions These results suggest that with lower levels of bifidobacteria, celiac patients have an imbalance in the intestinal microbiota, regardless of pH, even while on a gluten-free diet. This fact could favor the pathological process of the disorder. .


Contexto A ingestão do glúten é responsável pelos sintomas da doença celíaca, mas outros fatores ambientais também podem influenciar. Tem sido mostrado que as cepas do género Bifidobacterium proporcionam proteção contra a resposta inflamatória, lesão da mucosa causada por péptidos da gliadina in vitro. Objetivos Este estudo foi desenvolvido para comparar as concentrações de bifidobactérias e pH fecal de pacientes com doença celíaca em dieta isenta de glúten e indivíduos controles, a fim de identificar se o desequilíbrio na microbiota fecal ainda permanece durante o tratamento da doença celíaca e, identificar a necessidade de suplementação alimentar com pré ou probióticos. Métodos Foram analisadas as fezes de 42 indivíduos saudáveis e 14 pacientes com doença celíaca. A contagem de bifidobactérias nas fezes foi feita em meio seletivo BIM-25. A análise microscópica das colônias foi realizada por coloração de Gram. A identificação do género Bifidobacterium foi realizada por determinação de phosphoketolase frutose-6-fosfato. O pH fecal foi medido usando um medidor de pH. Resultados As concentrações de bifidobactérias por grama de fezes foi significativamente mais elevada nos indivíduos saudáveis (controles) (1,5 ± 0,63 x108 UFC/g), quando comparada com pacientes com doença celíaca (2,5 ± 1,5 x107 UFC/g). O pH fecal não foi diferente entre pacientes celíacos (7,19 ± 0,521) e controles (7,18 ± 0,522). Conclusões Estes resultados sugerem que, com concentrações inferiores de bifidobactérias, pacientes com doença celíaca tem um desequilíbrio na microbiota intestinal, independentemente do pH, mesmo durante uma dieta isenta de ...


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Bifidobacterium/growth & development , Celiac Disease/diet therapy , Celiac Disease/microbiology , Diet, Gluten-Free , Feces , Bifidobacterium/isolation & purification , Case-Control Studies , Colony Count, Microbial , Feces/chemistry , Feces/microbiology , Hydrogen-Ion Concentration
SELECTION OF CITATIONS
SEARCH DETAIL